SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRAV.L Regulatory News (RAV)

  • There is currently no data for RAV

Scrip Dividend Circular

3 Mar 2011 07:00

RNS Number : 1066C
Raven Russia Limited
03 March 2011
 



 

 

RAVEN RUSSIA LIMITED (the "Company")

 

Scrip Dividend Circular

 

 

Further to the Company's announcement on 17 February 2011, the circular relating to the scrip dividend for the Preference Shares for the period from 31 December 2010 to (but excluding) 31 March 2011 (the "Circular") is now available on the investor page of the Company's website, www.ravenrussia.com. A letter notifying holders of Preference Shares of the presence of the Circular on the Company's website and how to access it has been posted today together with a form of election (or an entitlement advice to the extent shareholders have already elected to participate in the scrip dividend mandate scheme).

 

The last date for receipt of completed forms of election (in accordance with the terms thereof) will be 18 March 2011.

 

Enquiries

 

Raven Russia Limited Tel: + 44 (0) 1481 712955

Anton Bilton

Glyn Hirsch

 

Cardew Group Tel: + 44 (0) 207 930 0777

Tim Robertson

Catherine Maitland

 

Singer Capital Markets Limited (NOMAD) Tel: +44 (0) 203 205 7500

Corporate Finance- James Maxwell

Sales - Alan Geeves / James Waterlow

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEALDFEAAFEFF
Date   Source Headline
14th Jul 20175:30 pmRNSDirector/PDMR Shareholding
14th Jul 20173:00 pmRNSTotal Voting Rights
13th Jul 20177:00 amRNSResult of AGM and Tender Offer
3rd Jul 20174:00 pmRNSResult of General Meeting
3rd Jul 20177:00 amRNSTotal Voting Rights
30th Jun 20177:00 amRNSDirector/PDMR Shareholding
29th Jun 20177:00 amRNSIssue of Preference Shares
20th Jun 20175:29 pmRNSDirector/PDMR Shareholding
13th Jun 20175:15 pmRNSResult of Placing of Convertible Preference Shares
1st Jun 20177:00 amRNSPreference Share Dividend
31st May 201710:30 amRNSTotal Voting Rights
25th May 20177:00 amRNSScrip Dividend Circular
17th May 20177:00 amRNSMoU signed with Russian Co-Op
16th May 20175:10 pmRNSProposed Placing
11th May 20177:00 amRNSPreference Share Dividend
8th May 201712:07 pmRNSSecond Price Monitoring Extn
8th May 201712:02 pmRNSPrice Monitoring Extension
3rd May 20176:15 pmRNSTotal Voting Rights
3rd May 20175:34 pmRNSDirector/PDMR Shareholding
26th Apr 20174:30 pmRNSUpdate Regarding Acquisition
21st Apr 20173:15 pmRNSDirector/PDMR Shareholding
3rd Apr 20177:00 amRNSTotal Voting Rights
31st Mar 20177:00 amRNSDirector/PDMR Shareholding
30th Mar 20177:00 amRNSIssue of Preference Shares
13th Mar 20177:00 amRNSFinal Results
9th Mar 201712:00 pmRNSPreference Share Dividend
1st Mar 20177:00 amRNSAcquisition Update
23rd Feb 20177:00 amRNSScrip Dividend Circular
9th Feb 20177:00 amRNSPreference Share Dividend
2nd Feb 20177:00 amRNSBlock listing Interim Review
25th Jan 20177:00 amRNSDirector Declaration
19th Jan 20174:30 pmRNSAcquisition and Notice of Results
3rd Jan 20177:05 amRNSDirector/PDMR Shareholding
3rd Jan 20177:00 amRNSTotal Voting Rights
30th Dec 20167:00 amRNSIssue of Preference Shares
21st Dec 20164:00 pmRNSDirector/PDMR Shareholding
8th Dec 20164:00 pmRNSDirector/PDMR Shareholding
1st Dec 20167:00 amRNSConvertible Preference Share Dividend
24th Nov 20167:00 amRNSScrip Dividend Circular
10th Nov 20167:00 amRNSPreference Share Dividend
7th Nov 20163:00 pmRNSDirector/PDMR Shareholding
1st Nov 20167:00 amRNSTotal Voting Rights
31st Oct 20165:30 pmRNSDirector/PDMR Shareholding
14th Oct 20165:00 pmRNSResult of General Meeting and Tender Offer
14th Oct 201612:07 pmRNSSecond Price Monitoring Extn
14th Oct 201612:02 pmRNSPrice Monitoring Extension
10th Oct 201612:07 pmRNSSecond Price Monitoring Extn
10th Oct 201612:02 pmRNSPrice Monitoring Extension
3rd Oct 20167:00 amRNSTotal Voting Rights
30th Sep 20167:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.